Re­gen­eron boost­ed, ri­val Es­pe­ri­on slammed as in­vestors scram­ble to catch up to a PC­SK9 price war

The big news over the week­end head­lined at #ACC18 in Or­lan­do, as Re­gen­eron $REGN and Sanofi $SNY pulled the cov­ers off of da­ta show­ing that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.